<?xml version="1.0" encoding="UTF-8"?>
<p id="par0240">Immunoglobulins have been widely used in medical practice, and their use has shown clinical benefits in previous studies of SARS and MERS. IVIG is currently under investigation for treatment of COVD-19 [
 <xref rid="bib0190" ref-type="bibr">38</xref>,
 <xref rid="bib0345" ref-type="bibr">69</xref>,
 <xref rid="bib0385" ref-type="bibr">77</xref>]. A case series of 3 severe COVID-19 patients who received high-dose IVIG (0.3–0.5 g/kg/day) for five days was reported [
 <xref rid="bib0385" ref-type="bibr">77</xref>]. All patients experienced clinical improvement shortly after administration. However, other therapeutic agents were administered for these patients including antivirals and a short course of steroids.
</p>
